TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation

Michael D. Oberst(National Institutes of Health), Kathleen Kelly(Center for Cancer Research)
BMC Cancer
July 2, 2008
Cited by 50


Related Papers